Desperate long COVID patients are seeking out “miracle cures.” Up to 23 million Americans have lingering symptoms that could be described as long COVID. (The Guardian

The cryptocurrency industry is outspending Big Pharma on lobbying. Cryptocurrency advocates gave $26 million in political donations from the start of 2021 through March 2022, well outpacing drugmakers. (Bloomberg)

A novel immunotherapy shrunk a woman’s late-stage pancreatic cancer, according to a study published in the New England Journal of Medicine. The patient isn’t cured but said what’s left of her cancer has shown no sign of growth since the one-time treatment in June 2021. (Associated Press)

Novartis resumed conducting business in Ukraine after reviewing safety protocols. The Swiss pharma giant has provided more than $33 million in medical aid, including more than 1.3 million packs of antibiotics, painkillers, cardiovascular and oncology treatments to Ukrainians and those seeking refuge in border areas. (Seeking Alpha)

Roche is partnering with up-and-coming drug developer Repare Therapeutics. The small-cap biotech handed over the rights to its lead drug candidate for an upfront cash payment of $125 million and the potential to receive up to $1.2 billion in additional milestones. (TheStreet)